See You at the AACR Annual Meeting 2026
Join us at booth #603 to explore cancer detection, targeting, and biomarker research solutions powered by 50 years of expertise.
At the AACR Annual Meeting 2026 in San Diego, Vector Laboratories is showcasing how its integrated reagents, bioconjugation expertise, and custom services enable researchers to solve complex challenges in cancer detection, targeting, and biology—from everyday workflows to bespoke solutions.
Antibodies & Detection Solutions
Validated reagents for spatial biology and IHC and IF cancer research workflows, enabling high-confidence tissue and biomarker analysis.
Glycosylation & Glycobiology
Lectin-based reagents and tools to visualize protein glycosylation in situ for new insights into disease biology, biomarker discovery, and tumor microenvironments.
Custom Antibody Services
Recombinant antibody engineering, sequencing, and expression tailored to your unique molecule and requirements.
Bioconjugation Reagents & Services
Broad collection of cross-linkers, payload linkers, labels, and bioconjugation services for optimized, customized detection and delivery
Featured Poster Presentations
Novel tools for spatial profiling of protein glycosylation in cancer biology
19 April 2026 | 2:00-5:00 PM
Poster Location: 32
Poster Board Number: 3
Poster Number: 791
Advancing spatial oncology research with open-panel multiplex IHC/IF using a novel heat-free antibody stripping reagent
19 April 2026 | 2:00-5:00 PM
Poster Location: 29
Poster Board Number: 7
Poster Number: 717
Advancing precision oncology through innovative bioconjugation and linker architecture strategies
20 April 2026 | 9:00 AM-12:00 PM
Poster Location: 38
Poster Board Number: 11
Poster Number: 2403
Comparing potential bispecific formats comprising of trastuzumab and a humanized OKT3
21 April 2026 | 9:00 AM-12:00 PM
Poster Location: 11
Poster Board Number: 17
Poster Number: 4409
Featured Resource
How Engineered Antibodies and Modular Chemistry Create Functional Biologics
This poster presents how Vector Laboratories’ modular chemistry approach integrates antibody engineering, bioconjugation, and linker design to enable flexible, precise construction of biological such as antibody drug conjugates for optimized therapeutic performance.
